Style Editor Docs
     
  • RadioGel™
    • Precision Radionuclide Therapy (PRnT)
    • Research (White Papers)
    • US FDA IDE Application
      • US FDA IDE Pre-Submission Process
    • Human Clinical Trials
  • IsoPet®
    • Regional Clinics
      • IsoPet® Therapy Dog • Cat Application
      • IsoPet® Therapy Equine Application
    • IsoPet® Therapy Pets
    • Veterinarians
    • Animal Studies
      • Canine Studies
      • Feline Studies
    • Our IsoPet® Mission
  • About Us
    • Management & Consultants
    • Advisory Boards
    • Contact - RadioGel™ | IsoPet®
  • Blog
  • Vivos Inc.
    • Press Releases
    • Board of Directors
    • SEC Filings
    • Contact - Investor Relations
   Contact Us
  • RadioGel™
    • Precision Radionuclide Therapy (PRnT)
    • Research (White Papers)
    • US FDA IDE Application
      • US FDA IDE Pre-Submission Process
    • Human Clinical Trials
  • IsoPet®
    • Regional Clinics
      • IsoPet® Therapy Dog • Cat Application
      • IsoPet® Therapy Equine Application
    • IsoPet® Therapy Pets
    • Veterinarians
    • Animal Studies
      • Canine Studies
      • Feline Studies
    • Our IsoPet® Mission
  • About Us
    • Management & Consultants
    • Advisory Boards
    • Contact - RadioGel™ | IsoPet®
  • Blog
  • Vivos Inc.
    • Press Releases
    • Board of Directors
    • SEC Filings
    • Contact - Investor Relations
  1. IsoPet®
  2. IsoPet® Therapy Pets

Brew - Our featured pet currently undergoing IsoPet® Therapy

Latest Update: January 25, 2023. - scrolling is in chronological order.

Reviewing any animal for IsoPet® Therapy can sometimes pose quite a challenge. When we're dealing with applicants that have an animal with an aggressively growing tumor, numerous items require assessment. Not every pet is a candidate for our treatment.

 

With each treatment, we take time to learn and study just how effective and efficient our Precision Radionuclide Therapy (PRnT®) device is. We use each case to research, and apply that experience too continually improving our product.

 

We would describe this case with Brew as very challenging; with no other good options except amputation. 

Pet Patient Expression of Interest: Brew

  • Pet Breed: Labrador Retriever
  • Pet Age: 11yrs 10mo
  • Pet Approximate Weight: 90lbs
  • General Health: good
  • Health issues other than the tumor: Soft tissue lumps on other parts of body which Vet (Dr. Walkenhorst of Paws, Claws & Hooves Veterinary Center West Richland WA) described as normal and non-threatening for a dog of this age.
  • Approximate Tumor Shape: Round to ellipse
  • Approximate Tumor Dimensions (Length | Width | Thickness: L 2-3/4" W 1-7/8" T 1-1/2"
  • Tumor Location: Right Front Paw (abaxial aspect of digit 2 of the right front carpus) as stated in the FNA Report
  • Tumor Type (if known): High suspicion for Sarcoma Cancer
  • Slow or fast growing – e.g. Approximate length of time since first observed: Probably started to notice an issue very early Spring 2022 and has been at full growth since May?
  • Recurring tumor?: No
  • Previous Tumor Therapies (if selected, medical records will be requested).: No therapies until some sores on the growth opened and required bandaging due to bleeding. Typically it gets fresh bandage twice a day. Bleeding seems to stop when some pressure is applied but open sore(s) will not heal.
  • Dr. Walkenhorst of Paws, Claws & Hooves Veterinary Center, West Richland, WA took blood samples and sent to lab/pathology 6/4/22. Results point to Sarcoma Cancer.

Pre-therapy assessment photos

  • Note: After these photos taken and the application submitted; the tumor had grown and split open before therapy.

As per the instruction for determining tumor size, the location of the tumor is on the right front paw. The technical description from the pathology report is that the tumor mass is on the abaxial aspect of digit 2 of the right front carpus.

IsoPet® Therapy performed Friday, October 14, 2022

Vista Veterinary Hospital, Kennewick, WA

IsoPet® Therapy was performed by veterinarian Dr. Geoffrey Goebel – the second certified vet at Vista Veterinary Hospital in Kennewick, WA.

 

Therapy was conducted the week of Friday October 14, 2022. 

 

A very important point is that we are trying to prevent an amputation, to an otherwise healthy dog.

 

 

About Dr. Goebel.

 

Dr. Goebel is a 2007 graduate of Washington State University School of Veterinary Medicine, after attending the University of Washington for his undergraduate degree in zoology. Dr. Goebel and his wife enjoy their Welsh Terrier, Manchester, and their cat named Santa's Little Helper. He enjoys golf, billiards, tennis and coaching youth soccer. Dr. Goebel's professional interests surround surgery, exotic pet and avian medicine.

 

Follow Up Friday, October 21, 2022 – (7 Days Post IsoPet® Therapy)

Note: We plan to add progress photos at two (2) week intervals if possible. ( This will be based upon receiving authorized photos from the Pet Parent )

Attached pics show the tumor and measurements just over one (1) week post surgery Friday, October 21, 2022.

 

Measurements:

 

L - ~3-1/4" | W - ~1-11/16" | H - ~2-1/8"

 

Friday, November 4, 2022 – (21 Days Post IsoPet® Therapy)

We planned on releasing progress photos this past week. However, they're pretty graphic, and we've decided to wait an additional period of time.

 

This was a complex treatment. Before IsoPet® Therapy, the tumor had grown and burst through the skin, and a part was surgically removed. After that, the open-treated wound became infected. Brew required antibiotics and additional bandaging. It is now beginning to settle down. 

 

The tumor has decreased in size and is soft, which is a good sign that it is necrotic, but not photogenic.

 

Thank you.

Friday, November 18, 2022 – (35 Days Post IsoPet® Therapy)

Brew is still undergoing the effects of the open sore that we encountered before the IsoPet® therapy. It is our recommendation that the Pet Parent visit Vista Veterinarian Clinic after Thanksgiving Day to assess the treated area.  As we mentioned in the outset of treatment, these types of tumors can become unpredictable.

 

Once Brew has completed his follow up examination appointment, we expect to hear further news from Dr. Myers and Dr. Goebel on their assessment.

 

Thank you.

 

Saturday, December 31, 2022 – (78 Days Post IsoPet® Therapy)

The pet parent just sent us an email update on Brew.

 

"The open area where the tumor was located has a good granulation bed and is contracting. The vet does not expect any more surgery. Brew is walking and putting pressure on that foot. The vet will take a look in about a month. Bandaging is optional at this point, and I plan to stop bandaging in about a week and let the area scab over."

 

This is amazing. This was advanced cancer that had broken through the skin. Because of the open wound, it became infected after therapy and had to be treated with antibiotics.

 

The cancer was advanced and had killed a large amount of healthy tissue, but the IsoPet® therapy killed the cancer. The animal could not resorb that much necrotic tissue*, so it was surgically removed. Now it appears to be healing. We're trusting in the process that IsoPet® may defiantly saved an amputation.

 

* What is necrotic tissue, and should it be removed?

 

Necrotic tissue is dead or devitalized tissue. This tissue cannot be salvaged and must be removed to allow wound healing.

Wednesday, January 25, 2023 – (103 Days Post IsoPet® Therapy)

The pet parent just emailed an update on Brew along with photos..

 

"The vet is very pleased with the healing progress, he does not see any reoccurrence of tumor at this point. The wound site has contracted to about quarter size and bandaging is minimal. Great success story. See attached pic(s).

 

Brew and I thank you for his return to a more normal life." – Duane

Brew's cancer was advanced and had killed a large amount of healthy tissue, but the IsoPet® Precision Radionuclide Therapy killed the tumor. The animal could not resorb a large amount of necrotic tissue*, so Dr. Goebel surgically removed it. Now it clearly is healing. We're trusting in the process that IsoPet® saved an amputation.

(Mike Korenko, Sc.D • CEO • President – Wednesday January 25, 2023)

 

The results from this IsoPet® Therapy continue to be excellent. As previously mentioned, Brew had very advanced cancer that had broken through the skin. After IsoPet® Therapy, the open wound became infected and required treatment with antibiotics.

 

The cancer was advanced and had killed a large amount of healthy tissue, but the IsoPet® Precision Radionuclide Therapy killed the tumor. The animal could not resorb a large amount of necrotic tissue*, so Dr. Goebel surgically removed it. Now it clearly is healing. We're trusting in the process that IsoPet® saved an amputation.

 

* What is necrotic tissue, and should it be removed?

 

Necrotic tissue is dead or devitalized tissue. This tissue cannot be salvaged and must be removed to allow wound healing.

Vivos, Inc.

Precision Radionuclide Therapy (PRnT)

OTCQB: RDGL

contact: info@radiogel.com


Home Page Cover Image: 

 

Veterinarian Dr. Michelle Myer from Vista Veterinarian Hospital in Kennewick, WA.

 

Seen here administering IsoPet® therapy to a feline suffering from a sarcoma.

RadioGel™ is a hydrogel liquid containing tiny yttrium-90 (90Y)  phosphate particles that may be administered directly into a tumor. The hydrogel is an yttrium-90 carrier at room temperature that gels within the tumor interstitial spaces after injection to keep the radiation sources safely in place. The short-range beta radiation from yttrium-90 localizes the dose within the treatment area so that normal organs and tissues are not adversely affected.

IsoPet® Therapy Application(s)


Precision Radionuclide Therapy (PRnT)


Vivos Inc.
 - (OTCQB: RDGL) Investor Relations 

Contact

 

Main colors
   bg-primary
   bg-primary-light
   bg-primary-dark
   bg-secondary
   bg-secondary-dark
Template sections
   body
   top-header
   header
   content
Footer Styles
   background
   text color
   link color
   horizontal line
Buttons
   style 1
   style 2
   style 3
Other elements
  social icons
  navigation color
  subnav background
Mobile navigation
   background color
   navigation color
Template configurations
has-right-nav g-font
navigation styles
size-15 weight-400 snip-nav
content styles
form-white
footer styles
o-form color-white
Typography
Heading H1
weight-600
Heading H2
weight-600
Heading H3
weight-600
Buttons
weight-600 is-uppercase
Animations

Note:
All changes made here will be applied to your entire website.
is-switcher admin-only

RadioGel™ Logo

Precision Radionuclide Therapy (PRnT)

draggable-logo

About | Privacy Policy | Cookie Policy | Sitemap
© 2023 Vivos Inc. | RadioGel™ is a registered trademark | IsoPet® is a registered trademark
Log out | Edit
  • Regional Clinics
  • IsoPet® Therapy Pets
  • Veterinarians
  • Animal Studies
  • Our IsoPet® Mission
  • Scroll to top